
Immune surveillance study shows pandemic interventions suppressed viral exposure in children, driving post-COVID resurgence and future outbreak risk.

Immune surveillance study shows pandemic interventions suppressed viral exposure in children, driving post-COVID resurgence and future outbreak risk.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

In recent studies, donidalorsen (Dawnzera) has demonstrated durable efficacy and long-term disease control.

Tacrolimus shows promise in treating juvenile myasthenia gravis, improving symptoms with minimal adverse effects, suggesting a valuable second-line therapy option.

Low-dose methylprednisolone is as effective as high-dose for severe pediatric MPP and has fewer side effects, supporting safer treatment strategies.

Controlling childhood EoE inflammation improves esophageal flexibility, reduces dysphagia risk, and may predict need for stricture dilation.

Young females with congenital heart disease face barriers to contraception, increasing their risk during pregnancy despite rising usage over time.

High-dose centanafadine significantly improved ADHD symptoms in children aged 6 to 12 years and was well tolerated, according to findings from a phase 3 clinical trial.

Biennial HPV testing and higher vaccination rates could help South Korea eliminate cervical cancer up to a decade earlier than current policy.

AAP updates guidance on recognizing and managing iatrogenic opioid dependence and withdrawal in children prescribed opioids.

The baby had mild respiratory distress after delivery and briefly required supplemental blow-by oxygen during transitioning.

Investigators noted the association was partially mediated by prepubertal adiposity.

If approved, vatiquinone would have been the first therapy approved for pediatric patients with FA.

The AAP recommends that all children aged 6 months to 23 months receive a COVID-19 vaccine, as this group has the highest risk for severe infection.

What's the diagnosis?

The AAP stated public health and trauma care should address "needs of injured children across the continuum of care."

Michael Haller, MD, discusses inhaled insulin’s safety, off-label use, and future role in easing type 1 diabetes management for children.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in 1 place.

Survey finds 30% of children missing school due to anxiety miss over a week; experts urge early intervention and therapy to address school avoidance.

Psychologist Elizabeth Reichert, PhD, encourages primary care providers to use validation and connection to support mental health during routine visits.

Among adolescents aged 13 to 17, coverage with 1 or more Tdap doses increased from 89% to 91.3% from 2023 to 2024.

Richard Auchus, MD, PhD, discusses how crinecerfont is improving CAH care and easing the transition from pediatric to adult management.

Higher maternal vitamin D in early pregnancy linked to better fluid and overall cognition in children, especially among those of Black mothers.

Results revealed students aged 10 to 13 years spent over 45 minutes on social media apps during school hours.

A minimum expiratory tidal volume of 4 mL/kg is associated with successful lung aeration during delivery room resuscitation of preterm neonates.

Discover essential nutrition tips for young athletes to enhance performance, hydration, and recovery before, during, and after sports activities.

FDA approves first generic iron sucrose injection for treating iron deficiency anemia in CKD patients 2 years and older.

Brensocatib was granted FDA priority review in February 2025 for the small molecule, oral, reversible inhibitor.

FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients ≥12 years.

Explore essential resources and toolkits for managing the ongoing stimulant medication shortage affecting ADHD treatment and patient care.